Clofibrate as an Adjunct to Phototherapy for Unconjugated Hyperbilirubinemia in Term Neonates
- 197 Downloads
To evaluate the efficacy of oral clofibrate as an adjunct to phototherapy for unconjugated hyperbilirubinemia in term neonates.
This randomized controlled trial was done in the level III neonatal intensive care unit (NICU) of a tertiary care hospital. Ninety term neonates with unconjugated hyperbilirubinemia with serum bilirubin 15–25 mg/dl were randomized to either intervention group (single dose of clofibrate in a dose of 50 mg/kg prior to starting phototherapy) or standard care group (only phototherapy). Primary outcome was absolute fall in bilirubin by 48 h. Secondary outcomes were duration of phototherapy, absolute fall in bilirubin levels at 12, 24, 36, 48 h, need for exchange transfusion and incidence of side-effects.
After 48 h of intervention, significantly lower bilirubin levels were noted in the intervention group compared to standard care group with a mean difference of 7 mg/dl (95% CI 6.7 mg/dl to 7.2 mg/dl). Duration of phototherapy required was less in the intervention group compared to standard care group with mean difference of 23.82 h (95% CI 30.46 h to 17.18 h). Exchange transfusion was needed for 4 neonates in the standard care group and none in the intervention group. No side-effects were noted with clofibrate.
Single dose clofibrate prior to starting phototherapy in term neonates with uncomplicated unconjugated hyperbilirubinemia reduces the duration of phototherapy significantly.
KeywordsNewborn Hyperbilirubinemia Clofibrate Phototherapy
PK: Collected and analyzed the data; BA: Helped with data analysis and drafted the manuscript; BVB: Supervised the study, edited the manuscript and will act as guarantor for the paper.
Compliance with Ethical Standards
Conflict of Interest
Source of Funding
- 1.Bhutani VK, Stark AR, Lazzeroni LC, et al; Initial Clinical Testing Evaluation and Risk Assessment for Universal Screening for Hyperbilirubinemia Study Group. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013;162:477–82. e1Google Scholar
- 8.Evidence based clinical practice guidelines -National Neonatology forum. Available at: http://www.nnfi.org/images/pdf/nnf_cpg_consolidated_file-january102011.pdf. Accessed on 22 March 2016.
- 12.Badeli HR, Sahrafi R, Sajedi SA. The effect of clofibrate on neonatal hyperbilirubinemia in uncomplicated jaundice. Iran J Ped. 2008;18:20–4.Google Scholar
- 16.Lindenbaum A, Hernandorena X, Vial M, et al. Clofibrate for the treatment of hyperbilirubinemia in neonates born at term: a double blind controlled study (author’s transl). [Article in French]. Arch Fr Pediatr. 1981;38:867–7.Google Scholar
- 17.Flores Nava G, Vargas Perez C, Lopez Padilla M, Escobedo Chavez E. Clofibrate in the prevention of neonatal hyperbilirubinemia. Pract Pediatr. 1996;5:40–6.Google Scholar